Perifosine Plus Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With Bortezomib: Results of a Multicenter Phase I/II Trial
RICHARDSON, Paul G, WOLF, Jeff, MARTIN, Tom, SCHLOSSMAN, Robert, GHOBRIAL, Irene M, MUNSHI, Nikhil, LAUBACH, Jacob, ALLERTON, Jeff, HIDESHIMA, Teru, COLSON, Kathleen, PORADOSU, Enrique, GARDNER, Lesa, JAKUBOWIAK, Andrzej, SPORTELLI, Peter, ANDERSON, Kenneth C, ZONDER, Jeff, LONIAL, Sagar, IRWIN, David, DENSMORE, John, KRISHNAN, Amrita, RAJE, Noopur, BAR, Michael
Published in Journal of clinical oncology (10.11.2011)
Published in Journal of clinical oncology (10.11.2011)
Get full text
Journal Article
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase 1b Study
Seymour, Erlene K., Li, Yiwei, Aboukameel, Amro, Ramchandren, Radhakrishnan, Sterbis, Golbon, Yang, Jay, Bhutani, Divaya, Mohammad, Ramzi, Azmi, Asfar Sohail, Zonder, Jeff
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Real-World Treatment Patterns in Patients with Light Chain (AL) Amyloidosis: Analysis of the Optum US Electronic Health Records and Commercial Claims Database
Dispenzieri, Angela, Zonder, Jeff, Hoffman, James, Wong, Sandy W., Liedtke, Michaela, Abonour, Rafat, D'Souza, Anita, Lee, Charlene, Nair, Sandhya, Potluri, Ravi, Weiss, Brendan M., Vermeulen, Jessica, Lam, Annette, Mehra, Maneesha
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Daratumumab (DARA) Plus Carfilzomib, Pomalidomide, Dexamethasone (KPd) in Lenalidomide Refractory Multiple Myeloma (MM): A Multi-Center MMRC Study
Jasielec, Jagoda, Zonder, Jeff, Derman, Benjamin A, Reece, Donna E., Cole, Craig E., Berdeja, Jesus G., Wolfe, Brittany, Major, Sarah, Tinari, Kathryn M., Stefka, Andrew, Fazzi, Fabrizio, Whelan, Megan, Gleason, Christine, McIver, Amanda, Andreatos, Evangelia, Libao, Bernadette M., Juergens, Daniel, Griffith, Kent, Jakubowiak, Andrzej
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Investigational CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study
Patel, Krish, Ramchandren, Radhakrishnan, Maris, Michael, Lesokhin, Alexander M., von Keudell, Gottfried R., Cheson, Bruce D., Zonder, Jeff, Seymour, Erlene K., Catalano, Tina, Lin, Gloria H.Y., Uger, Bob, Petrova, Penka S., Roberge, Kathleen, Shou, Yaping, Iyer, Swami P.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Understanding the Preferences of Patients and Caregivers for Relapsed/Refractory Multiple Myeloma Treatment: A Mixed-Mode Patient-Centric Approach
Auclair, Daniel, Mansfield, Carol, Chari, Ajai, Cole, Craig E., Fiala, Mark A., Kaufman, Jonathan L., Orloff, Gregory, Siegel, David, Zonder, Jeff A., Mange, Brennan, Yesil, Jennifer, Dalal, Mehul, Mikhael, Joseph
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes
Mohamed, Anwar N., Bentley, Gail, Bonnett, Michelle L., Zonder, Jeff, Al‐Katib, Ayad
Published in American journal of hematology (01.12.2007)
Published in American journal of hematology (01.12.2007)
Get full text
Journal Article
S0204: Melphalan (MEL)-Based Tandem Autotransplants (TAT) for Multiple Myeloma (MM) with Thalidomide/Dexamethasone (TD) Induction and Thalidomide/Prednisone (TP) Maintenance: A Phase II Trial of the Southwest Oncology Group
Hussein, Mohamad A., Jakubowiak, Andrzej J., Bolejack, Vanessa, Zonder, Jeff, Crowley, John, Barlogie, Bart
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article